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Abstract
Background: Expression of murine CCL21 by dermal lymphatic endothelial cells (LEC) has been
demonstrated to be one of the most important steps in Langerhans cell emigration from skin.
Previously, our group and others have found that this chemokine is up-regulated in different human
inflammatory skin diseases mediated by diverse specific immune responses. This study was carried
out to investigate the involvement of CCL21 in human skin after challenge with irritant agents
responsible for inducing Irritant Contact Dermatitis (ICD).
Results: Eleven normal individuals were challenged with different chemical or physical irritants.
Two patients with Allergic Contact Dermatitis (ACD) were also challenged with the relevant
antigen in order to have a positive control for CCL21 expression. Macroscopic as well as
microscopic responses were evaluated. We observed typical ICD responses with mostly
mononuclear cells in perivascular areas, but a predominance of polymorphonuclear cells away from
the inflamed blood vessels and in the epidermis at 24 hours. Immunohistochemical studies showed
up-regulation of CCL21 by lymphatic endothelial cells in all the biopsies taken from ICD and ACD
lesions compared to normal skin. Kinetic study at 10, 48, 96 and 168 hours after contact with a
classical irritant (sodium lauryl sulphate) showed that the expression of CCL21 was increased in
lymphatic vessels at 10 hours, peaked at 48 hours, and then gradually declined. There was a strong
correlation between CCL21 expression and the macroscopic response (r = 0.69; p = 0.0008), but
not between CCL21 and the number of infiltrating cells in the lesions.
Conclusions:  These results provide new evidence for the role of CCL21 in inflammatory
processes. Since the up-regulation of this chemokine was observed in ICD and ACD, it is tempting
to speculate that this mechanism operates independently of the type of dermal insult, facilitating
the emigration of CCR7+ cells.
Background
Skin derived Dendritic cells (DC) such as Langerhans cells
(LC) and interstitial DC play vital roles in immune sur-
veillance because they have efficient uptake and antigen
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presentation mechanisms. Antigens are captured and
processed, and few hours later DC reach peripheral lymph
nodes (PLN) via afferent lymphatics [1].
The molecular mechanisms that regulate DC emigration
are not fully understood. It seems to depend on the selec-
tive responsiveness of DC to special sets of signals.
Cytokines such as IL-1β, TNF-α, IL-18 [2], CCL19 [3], and
other molecules like Osteopontin [4], MMPs [5], prostag-
landins [6,7] leukotriene C4 [8] and, Lactoferrin [9], are
proved to regulate DC migration by several mechanisms.
One of the most important mechanisms is the up-regula-
tion of CCR7 in the emigrating DC, which seems to be
crucial for these cells to reach PLN through lymphatics
[10]. Only some subsets of DC and lymphocytes express
CCR7, allowing them to be attracted by the specific lig-
ands CCL21 and CCL19 [11].
CCL21 has been reported as the major chemokine respon-
sible for DC emigration from peripheral tissues [1,12].
This chemokine is expressed in murine and human high
endothelial venules (HEV) within secondary lymphoid
organs. Saeki et al demonstrated that mice lymphatic
endothelial cells (LEC) produce CCL21 [1], and more
recently a similar observation has been reported in
human normal skin [13]. Since it was discovered, CCL21
was classified as a constitutive chemokine. However our
group and others have clearly demonstrated up-regulation
of this chemokine by LEC and blood endothelial cells
(BEC) in different inflammatory skin diseases mediated
by specific immune response [13-15]. The selective
expression of CCR7 on immune cells, and the constitutive
and inflammatory CCL21 production would suggest two
different roles for this chemokine.
We conducted this study in order to investigate this chem-
okine in human irritant contact dermatitis (ICD). We
found a weak expression of CCL21 in dermal LEC from
normal skin; however after contact with several irritant
agents, CCL21 was up-regulated.
Results
As shown in Table 1 all irritant patch test reactions
induced by chemical agents were macroscopically classi-
fied as moderate (grade 2) or strong (grade 3) and physi-
cal agents induced weak (grade 1) or strong (grade 3)
macroscopic responses. Skin biopsies taken from Allergic
Contact Dermatitis (ACD) patients at 48 hours after con-
tact with specific antigens were classified as grade 3,
whereas normal skin biopsies from all individuals and a
skin biopsy from a patient with an empty patch were
grade 0 (no irritation) and 1, respectively.
Table 1: Individuals, contact agents and macroscopic responses
Subjects Contact agents Concentration (w/v) Time of exposition Macroscopic response#
Control skin
Normal skin from all patients - - 0
GN Patch alone - 24 h 1
Specific antigens
PF Nickel 5% 48 h 3
GL Peru Balsam 25% 48 h 3
Chemical agents
RL Aqueous Sodium Lauryl Sulphate 10% 24 h 2
EY Toluene undiluted 24 h 2
AR Trichloroacetic acid 35% 24 h 3
CL Sodium Hypochlorite undiluted 24 h 2
SD Salicylic Acid 30% 24 h 2
CM Sodium Hydroxide 10% 24 h 3
PC Glycolic Acid 70% 24 h 2
KM Benzalkonium chloride 5% 24 h 2
Phisical agents
KR Tape striping - 15 min 1
EE Liquid Nitrogen - 2 cycles of 15 sec 3
MA Ruda tea + UVA - 5 min 1BMC Immunology 2004, 5 http://www.biomedcentral.com/1471-2172/5/7
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Kinetic response
AJ SLS 10 % - 0
AJ SLS 10 % 10 h 1
AJ SLS 10 % 48 h 2
AJ SLS 10 % 96 h 1
AJ SLS 10 % 168 h 1
# Macroscopic response grading scale: no irritation = 0, weak = 1, moderate = 2, strong = 3
Table 2: Histological and Immunohistochemical studies in Contact Dermatitis
Subjects Contact agents Total number of inflamma-
tory cells in dermis (mm2)
DERMIS
Number of leukocytes (%) CCL21 expression 
in LEC*
Normal skin Inflamed skin Perivascular infiltrate Non-perivascular infiltrate
MC PC MC PC
Control skin
Normal skin from all patients - - ND ND ND ND 1
GN Patch alone 436 468 224 (47.9) 96 (20.5)7 6  ( 16.2)7 2  ( 15.4) 1
Haptens
PF Nickel 117 652 512 (78.5)1 6  ( 2.4)1 0 4  ( 16.0)2 0  ( 3.1) 3
GL Peru Balsam 44 1104 496 (44.9)6 0  ( 5.4)4 4 8  ( 40.6) 100 (9.1) 3
Chemical irritants
RL SLS 10% 292 988 152 (15.4)3 9 2  ( 39.7)4 3  ( 4.4)4 0 4  ( 40.9) 2
EY Toluene 568 1200 468 (39.0)1 6 8  ( 14.0)1 6 8  ( 14.0)3 9 6  ( 33.0) 3
AR Trichloroacetic acid 432 952 300 (31.5)1 3 2  ( 13.9)4 8  ( 5.0)4 7 2  ( 49.6) 2
CL Sodium Hypochlorite 540 948 108 (11.4)1 6 0  ( 16.9)9 6  ( 10.1)5 8 4  ( 61.6) 3
SD Salicylic Acid 324 608 276 (45.4)1 1 6  ( 19.1)3 2  ( 5.3)1 8 4  ( 30.3) 2
CM Sodium Hydroxide 616 1108 40 (3.6)2 3 6  ( 21.3)6 0  ( 5.4)7 7 6  ( 70.0) 2
PC Glycolic Acid 688 1768 191 (10.8) 1093 (61.8)1 9  ( 1.1)4 6 3  ( 26.2) 2
KM Benzalkonium chloride 488 1268 416 (32.8)6 3 4  ( 5.0)1 1 2  ( 8.8)6 7 6  ( 53.3) 3
Physical irritants
KR Tape striping 352 988 268 (27.1)2 3 2  ( 23.5)1 0 8  ( 10.9)3 8 0  ( 38.5) 1
EE Liquid Nitrogen 192 1824 111 (6.1)3 9 6  ( 21.7)7 7  ( 4.2) 1240 (68.0) 3
MA Rue + UVA 304 344 184 (53.5) 48 (13.9)8  ( 2.3)1 0 4  ( 30.2) 3
Statistical differences caused by 
exposure to irritant agents (p 
values)
p < 0.05 p > 0.05 p < 0.05
KINETIC STUDY
AJ-10 h SLS 10% 204 372 132 (35.5) 80 (21.5)4 4  ( 11.8)1 2 0  ( 32.2) 2
AJ-48 h SLS 10% 204 1032 548 (53.1)1 2 4  ( 12.0)1 2 4  ( 12.0)2 3 6  ( 22.9) 3
AJ-96 h SLS 10% 204 308 80 (62.5)4  ( 3.1)3 6  ( 28.1)8  ( 6.2) 1
AJ-168 h SLS 10% 204 456 512 (78.5)1 6  ( 2.4)1 0 4  ( 15.9)2 0  ( 3.1) 1
*CCL21 expression was semi-quantified as 0 = negative; 1 = weak; 2 = moderate; 3 = strong. Abbreviations: SLS, sodium lauryl sulphate; MC, 
mononuclear cells; PC, polymorphonuclear cells; ND, not done.
Table 1: Individuals, contact agents and macroscopic responses (Continued)BMC Immunology 2004, 5 http://www.biomedcentral.com/1471-2172/5/7
Page 4 of 8
(page number not for citation purposes)
The histopathological study of dermal blood vessels at 24
hours in ICD lesions showed a moderate hypertrophy and
swelling of endothelial cells with an important infiltration
of leukocytes when compared with normal skin (p < 0.05,
Table 2). When perivascular mononuclear cells (MC) or
polymorphonuclear cells (PC) cells were studied and
compared with infiltrating cells located away from the
blood vessels (non-perivascular) we found mostly PC (p
< 0.05) only in ICD. The inflammatory cells found out in
the epidermis were principally PC in most of the individ-
uals with ICD (9/11), but MC in patients with ACD (2/2)
(Table 2).
The kinetic study performed with 10% Sodium Lauryl Sul-
phate (SLS) showed at 10 hours a small number of
inflammatory cells being mostly PC in non-perivascular
areas when compared with perivascular areas (Table 2).
The total number of infiltrating cells in irritated skin
peaked at 48 hours and decreased significantly at 96 hours
and 168 hours.
In order to investigate CCL21 expression we performed
immunohistochemical studies with an amplifier system
to improve the sensitivity. Weak CCL21 expression was
found in all normal skin biopsies, but this expression
increased to moderate or intense in skin biopsies taken at
24 hours after contact with any of the irritant agents and
at 48 hours in the ACD patients (Figure 1 and Table 2). In
normal and damaged skin, CCL21 was found in small
sub-epidermal lymphatic vessels but in ICD and ACD
lesions it was also seen in lymphatic vessels next to blood
vessels surrounded by inflammatory cells (data not
shown). These findings were obtained in all biopsies inde-
pendently of the irritant agent applied.
When we investigated levels of CCL21 expression in the
skin biopsies obtained at different times from one ICD
patient we observed moderate levels of this chemokine at
10 hours, which further increased at 48 hours and
declined thereafter (Figure 2).
In some individuals with ICD we perform immunohisto-
chemistry in serial sections of several biopsies using anti
CCL21 and anti Prox-1 (specific marker for lymphatic ves-
sels). Vessels expressing CCL21 were also positive for
Prox-1, however we could not get good quality pictures
with this antibody (data not shown).
Positive correlation was found when we compared the
macroscopic response with CCL21 expression (r = 0.69; p
= 0.0008; CI = 0.34–0.87) but there was no correlation
between the number of infiltrating cells and CCL21
expression in all the patients studied (r = 0.29; p = 0.2155;
CI = -0.19–0.66).
Discussion
Irritant contact dermatitis (ICD) is a multifactor disease,
which involves a combination of endogenous and
exogenous factors. The exact mechanisms involved in ICD
responses are not fully understood. ICD can only be dis-
tinguished from allergic contact dermatitis (ACD) by
patch tests as histological examination of skin biopsies
from both entities shows MC infiltration at 48 hours [16].
In this study we observed in ICD patients a predominance
of PC in areas away from blood vessels and the epidermis
at 24 hours after contact with several irritants, whereas in
patients with ACD we previously found mostly MC in the
CCL21 expression in Contact Dermatitis Figure 1
CCL21 expression in Contact Dermatitis Immunohis-
tochemistry for CCL21 in biopsies taken from: normal skin 
(Control ICD); skin challenged with 10 % aqueous sodium 
lauryl sulphate at 24 hours (Positive ICD); non-challenged 
skin (Control ACD); and skin challenged with 5% Nickel at 
48 hours (Positive ACD). Insets shows the marked areas 
amplified in order to reveal the CCL21+ lymphatic vessels. 
400 × (original magnifications).BMC Immunology 2004, 5 http://www.biomedcentral.com/1471-2172/5/7
Page 5 of 8
(page number not for citation purposes)
dermis and epidermis as early as 10 h after challenge with
the relevant antigen [17].
These differences are probably due to the nature of the
immune responses in each entity; ICD is a non-immuno-
logical local reversible inflammatory reaction induced by
contact with irritants [18] whereas ACD is a specific
immune response mediated by Th1/Tc1 lymphocytes
[19]. In ICD, PC are attracted to the inflammatory area at
a very early stage followed by bystander lymphocytes. By
contrast, specific lymphocytes attracted to the site of hap-
ten contact in ACD and are responsible for the inflamma-
tory response.
In 1997 Hedrick et al.[20] and Nagira et al. [21], identified
a novel human CC chemokine mapped at chromosome
9p13. Using Northern blot analysis they found human
CCL21 expression restricted to lymphoid organs, while
murine CCL21 showed a broader tissue distribution with
the highest mRNA levels found in spleen and lung. Later
on, Gunn et al found CCL21 expression HEV from sec-
ondary lymphoid organs and lymphatics from several
murine tissues [22].
CCL21 expression by HEV has been reported to be
involved in CCR7+ naive lymphocytes recruitment in sec-
ondary lymphoid organs in human and mice [22-24].
Around the same time Saeki et al demonstrated that
CCL21 production by LEC is crucial for the emigration of
murine CCR7+ mature LC from the dermal compartment
[1].
A couple of years ago it was demonstrated by in vitro
experiments that human LEC constitutively secrete CCL21
at their basal side [25], and more recently Weninger et al.
found expression of this chemokine by LEC from normal
human skin using immunofluorescence staining [13].
Our previous studies and other investigations did not find
CCL21 expression by LEC in normal human skin. Since
these could be attributed to the low sensitivity of the assay
used, in the present study, we run an immunohistochem-
ical technique with a catalyzed amplification signal sys-
tem to increase the level of detection of this chemokine.
We reported here that all normal skin biopsies express low
levels of CCL21 in LEC.
Recent reports have provided evidence that CCL21 plays a
role during inflammatory processes. Up-regulation of this
Kinetics of CCL21 production during Irritant Contact Dermatitis Figure 2
Kinetics of CCL21 production during Irritant Contact Dermatitis Expression of CCL21 studied by immunohisto-
chemical assay in skin biopsies taken before (0 hours) and after contact with 10 % aqueous sodium lauryl sulphate at 10, 48, 96 
and 168 hours. Insets shows the marked areas amplified in order to reveal the CCL21+ lymphatic vessels. 400 × (original 
magnifications).BMC Immunology 2004, 5 http://www.biomedcentral.com/1471-2172/5/7
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chemokine by human BEC was demonstrated by Christo-
pherson et al using conventional immunohistochemistry
on skin biopsies taken from patients with inflammatory
skin diseases such as atopic dermatitis, lichen planus and
graft-versus-host [26]. Weninger et al performing
immunofluorescence staining found CCL21 expression
by BEC from rheumatoid arthritis and ulcerative colitis
biopsies, but not psoriasis where CCL21+ vessels were rare
[13]. They suggested that this could be related to the sig-
nificant number of CCR7+ T cells in biopsies from rheu-
matoid arthritis and ulcerative colitis patients, but not in
psoriasis, supporting the idea that CCL21 was only
recruiting naive T lymphocytes to rheumatoid arthritis
and ulcerative colitis tissues. These data identify CCL21
expression by BEC as an important determinant for naive
T cell migration to tertiary lymphoid tissues, and suggest
the CCL21/CCR7 pathway as a therapeutic target in dis-
eases associated with naive T cell recruitment.
On the other hand, our group and others have demon-
strated that up-regulation of CCL21 could also take place
in dermal LEC from patients with other diseases. In this
regard, Katou et al. have shown by RT-PCR and immuno-
histochemistry CCL21 expression only in LEC from
chronically inflamed skin infected with Candida albicans.
Moreover, the lymphocytes that infiltrate this inflamed
tissue were mostly CCR7- memory T cells [15].
Using in situ hybridization and immunohistochemistry,
we have previously found low levels of CCL21 in lym-
phatic vessels at 2 hours, which further increased at 10
and 48 hours in positive patch tests from patients with
ACD. Very low expression of this chemokine was
observed at 48 hours in skin biopsies from the sites chal-
lenged with an irrelevant antigen [14]. In this study we
showed that CCL21 up-regulation was not related with an
increase of CCR7+ infiltrating lymphocytes but it was asso-
ciated with the disappearance of Langerin+ cells from the
epidermis. Since Langerin is a marker of immature LC
[27], we speculate that under this inflammatory condition
the increased production of CCL21 could facilitate the
emigration of CCR7+  cells through lymphatic vessels.
Based on these evidences we have proposed that CCL21 is
probably much more than a constitutive chemokine [28].
In this paper we found that CCL21 is also up-regulated by
LEC during ICD by all of the irritant agents used. This up-
regulation was found as early as 10 hours and reached a
maximum level at 48 hours after contact with irritant
agents, and it correlated with the macroscopic response. It
is worth mentioning that Cumberbatch et al [29] have
shown that skin application of 10 % SLS in mice resulted
in a significant elevation of DC numbers in PLN, which
could also be mediated by up-regulation of this chemok-
ine by dermal lymphatics in those animals.
In spite of the fact that cytokines and chemokines involve-
ment in ICD and ACD responses has been broadly studied
[30-32], the molecular mechanisms responsible for up-
regulation of CCL21 remind to be elucidated. We are cur-
rently investigating this unanswered question.
Conclusions
Based upon these results, we concluded that two different
types of stress signals affecting the skin, antigen specific or
non-specific immune responses are capable of inducing
CCL21 up-regulation by LEC. This may enhance the
steady state emigration of CCR7+ LC.
Methods
Subjects
Thirteen healthy Caucasian volunteers, 7 males and 6
females were recruited from the Dermatological Clinic at
the Hospital Privado (Córdoba, Argentina). Their ages
ranged from 21 to 60 years (average = 35 years) and they
did not have any skin allergies or other illnesses. Two 46
years old women diagnosed as having ACD were also
studied. The Institutional Ethics Committee approved the
experimental protocols and all the subjects gave informed
consent. Individuals were not taking oral or topical medi-
cation during at least one month before the beginning of
this study.
Contact agents
In order to get objective ICD [33] individuals were
exposed to different irritants (8 chemicals and 3 physi-
cals) as shown in table 1. Chemical irritant agents were:
10% Aqueous Sodium Lauryl Sulphate (SLS), undiluted
Toluene, 35% Trichloroacetic acid, undiluted Sodium
Hypochlorite, 30% Salicylic Acid, 10% Sodium Hydrox-
ide, 70% Glycolic Acid 5% Benzalkonium chloride; and
30 µl of each irritant were applied at previous determined
concentrations in order to achieve a similar clinical
response at 24 hours (grade 2 or 3) [34]. The physical
agents used were: tape stripping, liquid nitrogen and con-
tact with rue (Ruta graveolens) followed by ultraviolet A
radiation (Waldmann Lichtechnik UV 7001 K) which pro-
duce a phytophototoxic reaction [35]. None of these irri-
tants caused the irreversible damage of the skin.
Specific antigens (30 µl of 5% Nickel or 25% Peru Bal-
sam) were applied in non-irritant concentrations in order
to get efferent responses in two patients already diagnosed
with ACD.
Chemical and contact agents were applied under 8-mm
Finn chambers on Scanpor tape (patches) at 5 cm of the
spine.BMC Immunology 2004, 5 http://www.biomedcentral.com/1471-2172/5/7
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Study design and samples collection
The normal individuals and the two patients with ACD
were challenged with one of the irritant agents and their
relevant antigens respectively, as previously described.
One control individual was in contact with a patch
without any irritant (control patch). Macroscopic
responses were measured at 24 hours in the normal indi-
viduals and at 48 hours in the ACD patients, by evaluating
in a blinded way skin erythema, dryness, edema and
eschar formation using the following arbitrary units (0 =
no reaction, 1 = weakly positive reaction, 2 = moderately
positive reaction, 3 = strongly positive reaction) [30]. At
the time of the macroscopic read out, skin biopsies from
normal skin and patch sites from all these individuals
were taken after local anesthesia (1 ml of 2% xylocain).
In order to perform a kinetic study, four patches with 10
% (w/v) aqueous SLS were applied in the back of another
volunteer and macroscopic responses and biopsies were
taken from the irritated site at 10, 48, 96 and 168 hours.
A control biopsy from normal skin was also taken.
All tissue biopsies were immediately fixed in 4% buffered
formalin, pH 7.4 and then embedded in low-temperature
paraffin wax. Serial sections (5 µm) were cut from biop-
sies, mounted on 0.1% poly-L-lysine-coated slides, dried
overnight and stored at room temperature until use.
Histology and immunohistochemistry
One skin section from each biopsy was processed for his-
tological study and stained with haematoxylin/eosin. Two
pathologists examined all the slides blindly and made a
semiquantitative assessment of dermis infiltration, con-
gested or dilated vessels, vesicles, spongiosis and levels of
expression of CCL21.
The sections were counted in duplicate on 16 adjacent
fields at × 400 magnification blinded to the patient's clin-
ical status. The number of mononuclear cells and poly-
morphonuclear cells were counted per mm2.
For immunohistochemistry skin sections (6 mm) were
dewaxed, rehydrated and then boiled in Vector antigen
unmasking solution (catalog H-3300, Vector Lab., Inc.,
Burlingame, CA, USA) in an 850-W microwave oven for
10 min. The sections were then washed in phosphate buff-
ered saline (PBS pH 7.6) for 20 min and the endogenous
peroxidase activity in the skin was blocked with 3%
hydrogen peroxide (Catalyzed Signal Amplification Sys-
tem (CSA), DAKO Corporation, USA) for 5 min and sub-
sequently washed thoroughly with PBS. To block
unspecific sites, tissue samples were incubated with Block-
ing solution (CSA, DAKO Corporation, USA) in PBS for
10 min, incubated for 1 hours with goat anti human
CCL21 (SC-5808, Santa Cruz Biotechnologies) at 0.067
µg/ml or rabbit anti human Prox-1 (kindly provided by
Dr. Guillermo Oliver, Department of Genetics, St Judes
Children's Hospital, Memphis, USA) at 1/1000. After
washing, sections were incubated for 30 minutes with
anti-goat IgG-Biotin at 0.25 µg/ml (sc-2042, Santa Cruz
Biotechnologies). Isotype-matched immunoglobulins
were used as negative controls. After washing with PBS,
the slides were incubated with the amplification and
streptavidin solutions (CSA, DAKO Corporation, USA)
according to the manufacturer's instruction. All incuba-
tions were performed at room temperature in a humid
chamber, the reaction cascade was visualized by incuba-
tion with 3-amino-9-ethylcarbazole (AEC, Dako, USA) as
a substrate and the slides were counterstained with
haematoxylin.
Positive CCL21 staining was only found on lymph vessels
which were identified based on their characteristic histo-
logical appearance (irregular morphology, very thin walls,
absence of red blood cells, light projections toward the
light that are interpreted as valves), as well as their locali-
zation: distant from the infiltrating cells. The expression
of CCL21+ in lymphatics was semi-quantified using the
following criteria (0 = negative; 1 = weak; 2 = moderate; 3
= strong staining).
Statistical analysis
Variability of the parameters studied was analyzed using
Friedman's test and correlation coefficient was obtained
by Spearman's method with correction for tied values. For
all tests, p ≤ 0,05 was considered significant.
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